Gynecology Surgical Forceps Market Report 2024

The gynecology surgical forceps market size has grown strongly in recent years. It will grow from $11.48 billion in 2023 to $12.22 billion in 2024 at a compound annual growth rate (CAGR) of 6.4%. The growth observed in the historical period stemmed from increased demand for gynecological procedures, an aging population with associated women's health issues, advancements in minimally invasive surgery techniques, higher healthcare expenditure on women's health, prevalent gynecological disorders, expanded healthcare infrastructure, and greater awareness and accessibility to gynecological care.

The gynecology surgical forceps market size is expected to see strong growth in the next few years. It will grow to $15.75 billion in 2028 at a compound annual growth rate (CAGR) of 6.6%. Anticipated growth in the forecast period will be driven by a shift towards minimally invasive gynecological surgeries, stringent regulatory standards governing surgical equipment, a focus on patient-centered healthcare solutions, market expansion in emerging economies, adoption of sustainable and eco-friendly practices, and integration of digital health technologies in gynecology. Major trends expected in this period include advancements in surgical instrument materials, miniaturization of surgical tools for improved precision, incorporation of robotics and automation in gynecological surgeries, customization of surgical instruments for specific procedures, development of smart surgical instruments equipped with sensors, emphasis on ergonomic designs for surgeon comfort, and integration of telehealth and remote surgical guidance.

The rise in uterine and vaginal cancer cases is expected to drive growth in the gynecology surgical forceps market. Uterine cancer originates in the uterus, while vaginal cancer develops in the vagina, necessitating specialized medical care. Factors contributing to increased incidence include aging populations and lifestyle influences such as obesity, linked to higher estrogen levels that promote cancer. Gynecological surgical forceps aid in precise treatment, improving outcomes for patients undergoing procedures. For example, in January 2023, the American Cancer Society reported an estimated increase in deaths from uterine cervix cancer from 4,280 in 2022 to 4,310 in 2023, a rise of about 0.70%. Similarly, deaths from cancers of the vagina and other female genital organs rose from 1,630 to 1,740 during the same period, marking an increase of approximately 6.75%. Thus, the growing incidence of uterine and vaginal cancer is a key driver of the gynecology surgical forceps market.

Leading firms in the gynecology surgical forceps sector are prioritizing environmentally sustainable products, such as PVC-free disposable bipolar forceps, in response to global demand for sustainable healthcare solutions. These forceps, used in gynecological procedures, are manufactured without PVC and feature FSC-certified packaging for easier recycling, supported by ISO 14001 certification for environmental management. For instance, Duomed Group, in collaboration with Pheasant, launched the first PVC-free disposable bipolar forceps in July 2021, underscoring their commitment to sustainability. A subsequent iteration of these eco-friendly forceps has been introduced following extensive evaluation to minimize environmental impact while maintaining usability and design familiarity compared to traditional options.

In June 2021, Blackstone Inc., The Carlyle Group Inc., and Hellman & Friedman LLC, all US-based private equity firms, jointly acquired Medline Industries LP for $34 billion. This strategic acquisition is aimed at leveraging Medline's market leadership and revenue streams to generate financial gains. It also seeks to diversify Medline's product portfolio, enhance its international footprint, and strengthen its global supply chain infrastructure. Medline Industries LP, a US-based medical device manufacturer, specializes in producing a range of surgical instruments, including specialized gynecology forceps.

Major companies operating in the gynecology surgical forceps market are Medtronic plc, Stryker Corporation, Baxter International Inc., Boston Scientific Corporation, B. Braun Melsungen AG, Zimmer Biomet Holdings Inc., Olympus Corporation, Terumo Corporation, Smith And Nephew plc, CooperSurgical Inc., Teleflex Incorporated, KARL STORZ GmbH and Co. KG, Integra LifeSciences Holdings Corporation, CONMED Corporation, KLS Martin Group, Richard Wolf GmbH, Merit Medical Systems Inc., AngioDynamics Inc., Applied Medical Resources Corporation, MedGyn Products Inc., Sklar Surgical Instruments, Zavation Medical Products, Maxer Endoscopy GmbH.

North America was the largest region in the gynecology surgical forceps market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gynecology surgical forceps market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the gynecology surgical forceps market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Gynecology surgical forceps serve as specialized tools in gynecological procedures, facilitating the grasp, manipulation, or removal of tissue and other materials. These instruments are available in various shapes and sizes, each tailored for specific tasks such as clamping blood vessels, handling delicate tissues, or retrieving objects.

Key types of gynecology surgical forceps include allis forceps, artery forceps, and others. Allis forceps feature toothed ends designed for securely grasping and holding tissues during procedures such as hysterectomies and pelvic surgeries. These instruments find application across a range of procedures including laparoscopy, hysteroscopy, dilation and curettage, and colposcopy. They are utilized in diverse healthcare settings such as hospitals, ambulatory surgical centers, and other medical facilities.

The gynecology surgical forceps market research report is one of a series of new reports that provides gynecology surgical forceps market statistics, including gynecology surgical forceps industry global market size, regional shares, competitors with an gynecology surgical forceps market share, detailed gynecology surgical forceps market segments, market trends and opportunities, and any further data you may need to thrive in the gynecology surgical forceps industry. This gynecology surgical forceps market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The gynecology surgical forceps market consists of sales of products such as tenaculum forceps, foerster sponge forceps, and kocher forceps to assist with gripping, clamping, and manipulating tissues and instruments in various gynecological procedures. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.